What is CRSP's gross margin?

CRISPR (CRSP) has a gross margin of -3346% and a net margin of -8431%.

What is CRSP's P/E ratio?

Track CRISPR (CRSP) P/E ratio, ROE, and valuation metrics over time.

Where can I see CRSP's full financials?

See CRISPR (CRSP) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

CRISPR (CRSP) Financials — Revenue, Earnings, Cash Flow

$50.36

+0.46 (+0.92%)

Weekly Expected Move ±9.2%

$40 $44 $48 $53 $57

NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 31 · $4.9B mcap · 96M float · 1.99% daily turnover · Short 61% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

📊 Key Metrics

TTM

$3M

Revenue

-91.2% YoY

$-569M

Net Income

-47.4% YoY

$-401M

Free Cash Flow

-30.3% YoY

-3346.4%

Gross Margin

-8933.3%

Op. Margin

-8431.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-29.5%

ROA-25.2%

ROIC-149.8%

Valuation

P/E-8.5

P/B2.7

EV/EBITDA-5.0

Leverage

Debt/Equity0.21

Current Ratio13.32

Interest Cov.0.0x

Quality Scores

Piotroski F3/9

Altman Z6.85

Beneish M-2.48